Sleep and endocrine therapy in breast cancer.

Current Opinion in Endocrine and Metabolic Research
Kathleen Van DykJudith E Carroll

Abstract

Sleep disturbances and insomnia are common among breast cancer survivors, and can have a significant effect on quality of life and numerous other significant outcomes. Among risks for sleep disturbance is the introduction of anti-estrogen endocrine therapies. The possible contributing factors to sleep disturbance in endocrine therapy are complex, and include pre-existing sleep disorders, the effects of chemotherapy and other treatments, and concurrent symptoms such as hot flashes. In addition, sleep disturbance in menopause, the natural downregulation of reproductive hormones in older age, is a common occurrence, and can offer a model for understanding the high prevalence of sleep problems in breast cancer survivors on endocrine therapy, as well as suggesting possible treatments such as behavioral interventions and pharmaceuticals. Altogether, significantly more research is needed to better understand and address sleep disturbance in breast cancer survivors on endocrine therapy in order to support quality of life and treatment adherence.

References

Aug 8, 1998·Fertility and Sterility·R R Freedman
May 15, 2002·Neuroendocrinology·Frank P M Kruijver, Dick F Swaab
Aug 30, 2003·Brain, Behavior, and Immunity·Sandra Sephton, David Spiegel
Jul 13, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sonia Ancoli-IsraelLavinia Fiorentino
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josée SavardCharles M Morin
Sep 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vered StearnsClaudine Isaacs
Jun 28, 2006·Archives of Internal Medicine·Maurice M Ohayon
Sep 12, 2006·Sleep Medicine Reviews·Lavinia Fiorentino, Sonia Ancoli-Israel
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julienne E Bower
Feb 27, 2008·Journal of Pineal Research·A GonzalezE J Sanchez-Barcelo
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary ElkinsTimothy Keith
Feb 6, 2009·Menopause : the Journal of the North American Menopause Society·Mahéra Al-AkoumSylvie Dodin
May 6, 2009·Climacteric : the Journal of the International Menopause Society·N BigliaP Sismondi
Jan 15, 2011·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Matthias RostockHans Helge Bartsch
Jan 21, 2011·Lancet·Cornelis J H van de VeldeStephen E Jones
Sep 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annelies H BoekhoutJan H M Schellens
Oct 4, 2011·Obstetrics and Gynecology Clinics of North America·Howard M Kravitz, Hadine Joffe
Feb 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N Lynn HenryAnna Maria Storniolo
Jun 13, 2012·Breast Cancer Research and Treatment·Caitlin C MurphySally W Vernon
Aug 22, 2012·The Breast : Official Journal of the European Society of Mastology·Susanne Bokmand, Henrik Flyger
Apr 11, 2013·Menopause : the Journal of the North American Menopause Society·Massimiliano de ZambottiFiona C Baker
Sep 26, 2013·Menopause : the Journal of the North American Menopause Society·Elena ToffolPäivi Polo-Kantola
Apr 11, 2014·Breast Cancer Research and Treatment·Wendy Y ChenEva S Schernhammer
Sep 12, 2014·Clinical Interventions in Aging·Stephen MartinkovichJohn A Arnott
Oct 14, 2014·The Breast : Official Journal of the European Society of Mastology·Ana Rute CostaNuno Lunet
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A RoscoeGary R Morrow
Feb 18, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinJennifer J Griggs
Mar 28, 2016·Journal of Psychiatric Research·Katie Moraes de AlmondesBreno Satler Diniz
Nov 23, 2016·Menopause : the Journal of the North American Menopause Society·Sheila N GarlandJun J Mao
Mar 31, 2017·British Journal of Cancer·Claudia Trudel-FitzgeraldEva S Schernhammer

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.